LQDA - Liquidia Technologies Inc logo

LQDA

Liquidia Technologies Inc

Liquidia Technologies develops, manufactures, and commercializes therapies for rare cardiopulmonary diseases, focusing on treatments for pulmonary arterial hypertension (PAH) using advanced drug delivery technology, including inhaled and injectable formulations.

โš•๏ธ Healthcare NASDAQ Listed 2018 $ USD
$1,000 invested 5 years ago โ†’$26,433today

Score Overview

1 Year
Score9.2
Net Growth132.36%
Net TrendGrew
Net Income Consistencyโ€”
Rev Growth81.95%
Rev TrendGrew
Revenue Consistencyโ€”
5 Years
Score6.1
Net Growth164.50%
Net Trend40%
Net Income Consistencyโ€”
Rev Growth21x
Rev Trend80%
Revenue Consistencyโ€”
All Time
Score4.7
Net Growth141.98%
Net Trend50%
Net Income ConsistencyInconsistent
Rev Growth105x
Rev Trend75%
Revenue Consistency71%

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-06-25
$ 76.92โ€”
1 Year2025-06-25
$ 13.60465.59%
5 Years2021-06-25
$ 2.9126x
All Time2018-07-26
$ 11.106x

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Year
2026$ 288M$ 22M$ 222M
2025$ 158M-$ 68M$ 190M
2024$ 13M-$ 130M$ 176M
2023$ 17M-$ 78M$ 83M
2022$ 15M-$ 41M$ 93M
2021$ 12M-$ 34M$ 57M
2020$ 739.63K-$ 59M$ 65M
2019$ 8M-$ 47M$ 55M
IPO2018$ 2M-$ 53M$ 39M